Cellosaurus cell line UCD178 (CVCL

Cross-references
Cell line name	UCD178
Accession	CVCL_ZV46
Resource Identification Initiative	To cite this cell line use: UCD178 (RRID:CVCL_ZV46)
Comments	Group: Triple negative breast cancer (TNBC) cell line. Characteristics: Established from a patient-derived xenograft. Doubling time: 54.1 hours, 55.8 hours (Note=With 17-beta-estradiol) (PubMed=32576280). Omics: Transcriptome analysis by RNAseq. Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations	Gene fusion; HGNC; HGNC:7881; NOTCH1 + HGNC; HGNC:29006; SEC16A; Name(s)=SEC16A-NOTCH1 (PubMed=32576280).
Disease	Invasive breast lobular carcinoma (NCIt: C7950)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=32576280; DOI=10.1186/s13058-020-01300-y; PMCID=PMC7310532 Finlay-Schultz J., Jacobsen B.M., Riley D., Paul K.V., Turner S., Ferreira-Gonzalez A., Harrell J.C., Kabos P., Sartorius C.A. New generation breast cancer cell lines developed from patient-derived xenografts. Breast Cancer Res. 22:68.1-68.12(2020)
Encyclopedic resources	Wikidata; Q98133837
Entry history
Entry creation	02-Jul-2020
Last entry update	19-Dec-2024
Version number	7